Ensysce Biosciences, Inc.
ENSCNASDAQHealthcare● Active
$0.25
$-0.00(-0.43%)
Market Cap$2347288
P/E Ratio—
52W High$2.75
52W Low$0.23
Ensysce Biosciences, Inc. (ENSC) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ENSC · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $4.31M | $3.50M | $1.12M | $3.15M | $12.26M |
| Net Receivables | $0.42M | $0.12M | $0.10M | $0.28M | $0.44M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | ($0.44M) |
| Total Current Assets | $7.24M | $5.34M | $2.29M | $5.30M | $15.66M |
| PP&E Net | $124129.00M | $0.00M | $0.00M | $0.00M | $24721.00M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $7.45M | $5.60M | $2.71M | $5.89M | $16.42M |
| Liabilities | |||||
| Short-Term Debt | $306708.00M | $0.30M | $0.85M | $4.27M | $12.75M |
| Accounts Payable | $3.27M | $1.36M | $1.94M | $2.94M | $0.30M |
| Total Current Liabilities | $4.57M | $2.21M | $3.33M | $9.46M | $16.48M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.14M | $4.44M |
| Total Liabilities | $4.57M | $2.22M | $3.36M | $9.91M | $24.58M |
| Stockholders Equity | |||||
| Retained Earnings | ($139.72M) | ($129.54M) | ($121.56M) | ($110.93M) | ($85.85M) |
| Total Stockholders Equity | $3.21M | $3.71M | ($0.32M) | ($3.71M) | ($7.88M) |
| Total Liab & Equity(computed) | $7.78M | $5.93M | $3.04M | $6.20M | $16.70M |
| Debt Summary | |||||
| Total Debt | $306708.00M | $0.30M | $0.85M | $4.43M | $17.21M |
| Net Debt | $306703.69M | ($3.20M) | ($0.27M) | $1.29M | $4.95M |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Ensysce Biosciences, Inc. data
About Ensysce Biosciences, Inc. (ENSC) Balance Sheet
Ensysce Biosciences, Inc. (ENSC) balance sheet shows total assets of $0.01B with cash of $0.00B. Total liabilities are $0.00B, total debt $306.71B, and stockholders equity $0.00B.
Frequently asked questions
ENSC · 4 questionsEnsysce Biosciences, Inc. has total debt of $306.71B with net debt of $306.70B.
ENSC total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10